Sullivan et al. describe their finding that lower skin catalase activity in male as compared with female mice may be responsible for the increased skin carcinogenesis observed in UVB radiation-exposed male mice. This adds to the growing literature that points toward a gender bias in the pathogenesis of skin cancer. Delineating the events between UV exposure and carcinogenesis in relation to skin's antioxidant activity will provide insight into disease progression, prognosis, and responses to therapy. If substantiated with further studies in humans, this information may aid in designing gender-specific preventive measures aimed at reversing immune suppression through targeting the altered redox status in UV-exposed individuals.
Dermatologists have long witnessed more male than female patients with nonmelanoma skin cancer, which comprises approximately half of all diagnosed cancers in the United States. This assertion is supported by epidemiologic studies that report at least a twofold greater incidence of these cancers in men than in women (Schmitt et al., 2011) . A combination of increased exposure and neglect was thought to play a dominant role in this discrepancy. Studies showed that on average men spend more hours in the sun and are less likely to employ sun protection techniques. Three times more men than women avoid doctors when they have persistent, minor medical symptoms, and many neglect to obtain routine screenings for such conditions as cancers, even when sent reminders and offered free testing by their health plans (Schmitt et al., 2011) . However, the fact that this gender difference was observed both in epidemiologic studies of humans and in animal studies suggests it may not be attributable entirely to sociological differences but also to specific biological characteristics.
As our understanding of skin cancer increases, there is enhanced interest in delineating the role of gender differences in its pathogenesis. An earlier study demonstrated that male mice, upon exposure to UVB radiation, show more cutaneous oxidative DNA damage than do females and have lower antioxidant levels (Thomas-Ahner et al., 2007) . In their recent study, Sullivan et al. (2012, this issue ) showed that sex difference is an important predictor in responses to UVB-induced inflammation. UVB irradiation inhibited skin catalase activity and increased myeloid cell skin infiltration. Interestingly, catalase supplementation in male mice significantly inhibited UVB-induced cellular infiltration of the skin.
Solar UV is considered a major etiological factor in melanoma and nonmelanoma skin cancer. Reactive oxygen species (ROS) generated in response to UV irradiation participate in a number of pathophysiological processes, including DNA damage and lipid peroxidation, and they are thought to play important roles in tumor progression (Afaq and Mukhtar, 2002) . In response to the assault by ROS, cutaneous cells have developed several antioxidant defense systems, such as glutathione peroxidase, superoxide dismutase, and catalase, to protect against their detrimental effects.
Immunosuppression, attributed mainly to the UVB (290-320 nm) wavebands, is considered a prerequisite for skin cancer development in mice and humans. UV irradiation suppresses immunity through multiple mechanisms, including inhibition of antigen presentation, release of immunosuppressive cytokines, and the generation of regulatory lymphocytes (Afaq and Mukhtar, 2002) . Gr-1 + CD11b + myeloid cells, which express surface markers common to both macrophage (Mac-1/ CD11b) and granulocyte (Gr-1) lineages and display features of undifferentiated myeloid cells, have been shown to accumulate in the spleen and lymph nodes of tumor-bearing mice, where they inhibit antibody production, cytotoxic T-lymphocyte generation, and lymphocyte proliferative responses (Gabrilovich and Nagaraj, 2009 ). The accumulation of Gr-1 + CD11b + myeloid cells is often associated with a large tumor burden, and surgical resection of such tumors is associated with a decrease in the number of these cells in both human and mouse tumor models (Salvadori et al., 2000) . The immature myeloid cells obtained from tumor-bearing mice possess significantly higher levels of ROS than those isolated from tumor-free animals. Interestingly, hydrogen peroxide and not superoxide radical anions was found to be the major part of this increased ROS production, and catalase treatment resulted in a greater than fourfold decrease in ROS levels in these animals (Kusmartsev and Gabrilovich, 2003) .
Cellular antioxidants may therefore be considered molecules that, by augmenting the cellular defense systems, are ultimately responsible for cellularand probably organismic-longevity. Two studies, one in Drosophila and one in mice, have shown that overexpression of catalase in mitochondria results in a significant reduction in hydrogen peroxide generated by mitochondria and increased resistance to oxidative stress (Mockett et al., 2003; Schriner et al., 2005) . Especially informative is the murine study (Schriner et al., 2005) , in which an increase in expression of the mitochondrial catalase gene was associated with decreased oxidative stress resistance and increased life span.
The average life span of females is greater than that of males in several species, including rats and humans (Vina et al., 2008) . Different production of ROS may explain this difference in longevity. Recent reports suggest that male rats not only produce more peroxides than females but also are less protected by a key cellular thiol, glutathione. In addition, oxidatively damaged mitochondrial DNA was found to be approximately fourfold higher in males than in females, and oxidation of mitochondrial DNA has been shown to be related to a decline of cellular function with age (Vina et al., 2006) .
The presence of gender differences in the expression of antioxidant enzymes has been well documented. Studies in mice have shown profound differences in antioxidant responses with aging between sexes, with males displaying low levels of antioxidant enzymes such as superoxide dismutase, catalase, and glutathione reductase (Tomas-Zapico et al., 2006) . The brains of female mice have reportedly lower oxidant and higher antioxidant capacity than those of males, mostly related to catalase activity (Sobocanec et al., 2003) . Female rats display higher cytochrome c oxidase activity; consequently, mitochondria from female rats produce fewer ROS. In addition, they have an increased capacity to detoxify ROS due to higher superoxide dismutase and glutathione peroxidase activities (Vina et al., 2008) .
There is considerable evidence that the higher levels of estrogen in females protect them against aging by interacting with intracellular signaling pathways such as the mitogen-activated protein kinase, cyclic adenosine monophosphate pathways, and the redoxsensitive transcription factor nuclear factor-κB (Behl et al., 2000) . Further proof that estrogen prevents oxidative stress has come from animal studies in which ovariectomy caused a significant increase in mitochondrial peroxide production in rats. Moreover, when these ovariectomized rats were treated with estradiol, the rate of mitochondrial peroxide production decreased significantly. It was further noted that the low concentrations of estrogens present in plasma did not act as chemical antioxidants per se; however, they were able to activate a signal transduction program that resulted in the upregulation of antioxidant genes (Vina et al., 2006) .
Skin synthesizes locally significant amounts of sexual hormones with intracrine or paracrine actions. Emerging data support the concept that female sex hormones can also be protective in cutaneous carcinogenesis; in fact, Mancuso and colleagues (2009) recently reported that murine skin tumor development was significantly enhanced after ovarian hormone withdrawal in two independent experimental models. Increased basal and squamous cell tumor incidence and multiplicity, and decreased tumor latency were observed in ovariectomized versus intact controls, showing that endogenous estrogens play a critical role in protection against carcinogenesis by several agents in mouse skin.
The results of Sullivan and colleagues' study complement findings from several epidemiologic studies in humans as well as in animal experimental models reporting gender differences in skin cancer incidence. Dissecting the interplay between antioxidants and hormone signaling will be critical to gaining a better mechanistic understanding of the impact of gender on disease pathogenesis. However, several questions remain unanswered. Does the reduced activity of antioxidant enzymes, specifically catalases, in males represent direct steps in carcinogenesis? Given the inverse correlation between Gr-1 + CD11b + cell percentages and catalase activity, what is the mechanism by which these cells are regulated by the antioxidant enzyme system in response to UV irradiation? It will be interesting to explore the relative contribution of estrogen to the sexual dimorphism observed in skin tumorigenesis and its relationship to the myeloid suppressor cells.
Although they may not reflect the entire spectrum of cutaneous carcinogenesis, the findings of Sullivan et al.
(2012) extend our understanding of the underlying pathogenesis of the disease. Further work will be needed to determine whether catalase is useful in preventing or treating skin cancer. Chemical modification techniques have been used to control the tissue distribution of catalase, and the effectiveness of catalase delivery has been demonstrated in animal models for hepatic ischemia/reperfusion injury, chemically induced tissue injuries, and tumor metastasis to the liver, lung, and peritoneal organs (Nishikawa et al., 2009) . In this context, significant inhibition was observed in ROS-mediated oxidative tissue damage and ROS-mediated upregulation of the expression of genes responsible for recruiting inflammatory cells and for metastatic growth of tumor cells. Catalase can be used as a therapeutic agent, but its success will depend on entry of the enzyme into sites where ROS are generated. Because oxidative stress is implicated in several human diseases, catalase delivery could have wide application in the future. If substantiated in humans, this concept could aid in designing preventive measures and predicting the treatment outcomes of patients with skin cancer.
Clinical Implications
• Male mice are increasingly susceptible to skin carcinogenesis upon UVB radiation exposure as compared with their female counterparts; this finding is linked to decreased catalase activity in males versus females. • Catalase activity was inversely correlated with the expression of myeloid suppressor Gr-1 + CD11b + cells in the skin, emphasizing the specific regulatory role of this antioxidant on the immune system in response to UV irradiation. • If authenticated in humans, this approach may be a useful indicator of disease risk and aid in developing and evaluating strategies for countering carcinogenesis in susceptible populations. (Figure 1) . It was in the 1950s that Barbara McClintock formulated the molecular theory of somatic reversion of "unstable mutations": sections of chromosomes proposed to move into and out of genes. For her work on transposons she was awarded the Nobel Prize in 1983.
Revertant mosaicism was demonstrated in blood, muscle, liver, and skin
In humans, revertant mosaicism (RM) has been reported in genetic disorders affecting self-regenerating organ systems, such as blood, muscle, liver, and skin (for reviews, see Jonkman, 1999; Hirschhorn, 2003; Lai-Cheong et al., 2011) . The genetic mechanisms underlying spontaneous gene repair in humans are mostly second-site mutations (single-nucleotide transversions/ transitions and deletions) and homologous recombinations.
To observe RM in blood, muscle, or liver, a microscope and special staining are required, but in skin RM is visible to the naked eye. RM in skin was first reported by Jonkman et al. (1997) in the genetic disorder epidermolysis bullosa (EB), which is characterized by lifelong fragile skin that easily forms blisters and erosions. Mutations in as many as 15 genes can result in EB. Four of these genes have shown to revert: KRT14 encoding keratin 14 in EB simplex, LAMB3 encoding the β3 chain of laminin-332 (Pasmooij et
